BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16119039)

  • 1. Comparative effects of fexofenadine and montelukast on allergen-induced wheal and flare.
    White M; Rothrock S; Meeves S; Liao Y; Georges G
    Allergy Asthma Proc; 2005; 26(3):221-8. PubMed ID: 16119039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of the histamine-induced wheal and flare response by fexofenadine HCl 60 mg twice daily, loratadine 10 mg once daily and placebo in healthy Japanese volunteers.
    Boyle J; Ridout F; Meadows R; Johnsen S; Hindmarch I
    Curr Med Res Opin; 2005 Sep; 21(9):1495-503. PubMed ID: 16197669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of fexofenadine versus desloratadine in suppressing histamine-induced wheal and flare.
    Meltzer EO; Gillman SA
    Allergy Asthma Proc; 2007; 28(1):67-73. PubMed ID: 17390761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of montelukast (10mg daily) and loratadine (10mg daily) on wheal, flare and itching reactions in skin prick tests.
    Kupczyk M; Kupryś I; Górski P; Kuna P
    Pulm Pharmacol Ther; 2007; 20(1):85-9. PubMed ID: 16516511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative potency of fexofenadine HCl 180 mg, loratadine 10 mg, and placebo using a skin test model of wheal-and-flare suppression.
    Kaliner MA; White MV; Economides A; Crisalida T; Hale M; Liao Y; Christian CD; Georges GC; Woodworth TH; Meeves SG
    Ann Allergy Asthma Immunol; 2003 Jun; 90(6):629-34. PubMed ID: 12839321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar rapid onset of action and magnitude of effect of fexofenadine and cetirizine as assessed by inhibition of histamine-induced wheal-and-flare reaction.
    Purohit A; N'Gom AS; Deslandes B; Pauli G; Frossard N
    Ann Allergy Asthma Immunol; 2004 Dec; 93(6):562-7. PubMed ID: 15609766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of the early and late cutaneous allergic responses using fexofenadine and montelukast.
    Simons FE; Johnston L; Gu X; Simons KJ
    Ann Allergy Asthma Immunol; 2001 Jan; 86(1):44-50. PubMed ID: 11206237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twenty-four hours of activity of cetirizine and fexofenadine in the skin.
    Purohit A; Duvernelle C; Melac M; Pauli G; Frossard N
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):387-92. PubMed ID: 11345280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance.
    Takahashi H; Ishida-Yamamoto A; Iizuka H
    Clin Exp Dermatol; 2004 Sep; 29(5):526-32. PubMed ID: 15347340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fexofenadine decreases sensitivity to and montelukast improves recovery from inhaled mannitol.
    Brannan JD; Anderson SD; Gomes K; King GG; Chan HK; Seale JP
    Am J Respir Crit Care Med; 2001 May; 163(6):1420-5. PubMed ID: 11371412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of montelukast on wheal reactions in skin prick tests: a double-blind-placebo-controlled randomized trial.
    Bulan K; Aydogan M; Siraneci R; Aydogmus CY
    Int J Pediatr Otorhinolaryngol; 2013 Oct; 77(10):1655-8. PubMed ID: 23958393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
    Grant JA; Riethuisen JM; Moulaert B; DeVos C
    Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of butterbur on the histamine and allergen cutaneous response.
    Jackson CM; Lee DK; Lipworth BJ
    Ann Allergy Asthma Immunol; 2004 Feb; 92(2):250-4. PubMed ID: 14989395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of montelukast and fexofenadine for chronic idiopathic urticaria.
    Nettis E; Dambra P; D'Oronzio L; Loria MP; Ferrannini A; Tursi A
    Arch Dermatol; 2001 Jan; 137(1):99-100. PubMed ID: 11176678
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: duration of effect in subjects with seasonal allergic rhinitis.
    Day JH; Briscoe MP; Rafeiro E; Hewlett D; Chapman D; Kramer B
    Allergy Asthma Proc; 2004; 25(1):59-68. PubMed ID: 15055564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
    Moinuddin R; deTineo M; Maleckar B; Naclerio RM; Baroody FM
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of histamine or allergen-induced wheals by a single dose of acrivastine, fexofenadine or cetirizine.
    Ballmer-Weber BK; Gex-Collet C; Wüthrich B
    J Investig Allergol Clin Immunol; 1999; 9(6):351-5. PubMed ID: 10664928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy of wheal-and-flare suppression among various non-sedating antihistamines and the pharmacologic insights to their efficacy.
    Roongapinun S; Wajajamreon S; Fooanant S
    J Med Assoc Thai; 2004 May; 87(5):551-6. PubMed ID: 15222528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, single-dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratadine versus placebo: suppression of histamine-induced wheal and flare response for 24 h in healthy male subjects.
    Grant JA; Danielson L; Rihoux JP; DeVos C
    Allergy; 1999 Jul; 54(7):700-7. PubMed ID: 10442525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of cetirizine and fexofenadine for seasonal allergic rhinitis, 5-12 hours postdose, in the environmental exposure unit.
    Day JH; Briscoe MP; Rafeiro E; Ratz JD; Ellis AK; Frankish CW; Chapman D; deGuia EC; Kramer B; Warner C
    Allergy Asthma Proc; 2005; 26(4):275-82. PubMed ID: 16270720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.